• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

Mannkind up over 20% today

Anonymous

Guest
Inhaled insulin may yet come to be approved by FDA. Why did the Lilliputians give up?

Maybe someone got burned on their PM. Their feelings hurt. So they didn't cross that t, or dot that i. Happens in the best of families. Oooo Ahhhh.
 

<











Lilly couldn't get it done. Instead of hiring the best scientists we can find, we hire the most Chinese scientists we can find.

Millions and millions sold. It's not just the Engrish that is sometimes lacking.... beware of unscrupulous references, and decade-old universities that produce 100% A Students with distinguished creative research awards.